An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma

Biomarkers for resistance in Glioblastoma multiforme (GBM) are lacking, and progress in the clinic has been slow to arrive. CD133 (prominin-1) is a membrane-bound glycoprotein on the surface of cancer stem cells (CSCs) that has been associated with poor prognosis, therapy resistance, and tumor recur...

Descripción completa

Detalles Bibliográficos
Autores principales: Joyce, Thomas, Jagasia, Sarisha, Tasci, Erdal, Camphausen, Kevin, Krauze, Andra Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528301/
https://www.ncbi.nlm.nih.gov/pubmed/37754516
http://dx.doi.org/10.3390/curroncol30090601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528301/
https://www.ncbi.nlm.nih.gov/pubmed/37754516
http://dx.doi.org/10.3390/curroncol30090601

Ejemplares similares